| Name | Walgreens #13893 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1631 Dual Hwy, Hagerstown, Maryland 21740 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (240) 313-9165 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced that its Alere i RSV test has been granted CLIA (Clinical Laboratory Improvement Amendments) waiver by the U.S. Food and Drug Administration for the detection of RSV (respiratory syncytial virus) infection in children and adults.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Circuit Therapeutics today announced that it has been awarded a 2.7 million dollar contract from the Defense Advanced Research Projects Agency to pursue optogenetic therapies for peripheral nervous system indications. The award, part of DARPA's Electrical Prescriptions (ElectRX) program, will enable Circuit to pursue research and development projects related to its treatment for neuropathic pain.
A new study led by University of North Carolina School of Medicine researchers is the first large prospective study to evaluate musculoskeletal pain outcomes after motor vehicle collision in the U.S.
Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.
› Verified 6 days ago
| NPI Number | 1831436187 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #13893 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1631 Dual Hwy, Hagerstown, MD 21740 |
| Phone Number | 240-313-9165 |
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced that its Alere i RSV test has been granted CLIA (Clinical Laboratory Improvement Amendments) waiver by the U.S. Food and Drug Administration for the detection of RSV (respiratory syncytial virus) infection in children and adults.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Circuit Therapeutics today announced that it has been awarded a 2.7 million dollar contract from the Defense Advanced Research Projects Agency to pursue optogenetic therapies for peripheral nervous system indications. The award, part of DARPA's Electrical Prescriptions (ElectRX) program, will enable Circuit to pursue research and development projects related to its treatment for neuropathic pain.
A new study led by University of North Carolina School of Medicine researchers is the first large prospective study to evaluate musculoskeletal pain outcomes after motor vehicle collision in the U.S.
Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.
› Verified 6 days ago
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced that its Alere i RSV test has been granted CLIA (Clinical Laboratory Improvement Amendments) waiver by the U.S. Food and Drug Administration for the detection of RSV (respiratory syncytial virus) infection in children and adults.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will experience modest four percent annual growth from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Although the market will increase over the next decade, generic erosion will constrain sales of key branded agents such as Johnson & Johnson's Topamax (topiramate) and Pfizer's Celebrex (celecoxib).
Circuit Therapeutics today announced that it has been awarded a 2.7 million dollar contract from the Defense Advanced Research Projects Agency to pursue optogenetic therapies for peripheral nervous system indications. The award, part of DARPA's Electrical Prescriptions (ElectRX) program, will enable Circuit to pursue research and development projects related to its treatment for neuropathic pain.
A new study led by University of North Carolina School of Medicine researchers is the first large prospective study to evaluate musculoskeletal pain outcomes after motor vehicle collision in the U.S.
Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.
› Verified 6 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 919 Sweeney Dr, Hagerstown, Maryland 21740 Phone: (301) 791-5500 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 19833 Leitersburg Pike, Hagerstown, Maryland 21742 Phone: (301) 745-5922 | |
Equipped For Life Type: DME Supplier - Oxygen Equipment & Supplies Location: 525 Dual Hwy, Hagerstown, Maryland 21740 Phone: (301) 714-0200 | |
Optimal Health Care Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11377 Robinwood Dr, Hagerstown, Maryland 21742 Phone: (301) 790-4962 | |
Cvs Pharmacy #01435 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1503 Potomac Ave, Hagerstown, Maryland 21742 Phone: (301) 733-8515 |